NCT07103070

Brief Summary

This study is a single armed prospective case series designed to evaluate the efficacy of treating common structural-related foot ailments (i.e. plantar fasciitis, metatarsalgia, and/or hallux valgus) with a high quality non-custom made arch support. It is believed that these conditions are the result of inadequate or poorly fitted arch supports resulting in a lack of structural correction in the foot while weight bearing. Over-the-counter insoles are believed to counteract the shortcomings in foot structure that result in these painful conditions. In this study, it is proposed that changes in foot morphology can be measured quantitatively using weight bearing CT Scan (Computerized Tomography) and X-rays of the subject with and without the arch supports. Subjects will also answer questions from a validated series of questionnaires pertaining to their foot condition and generalized health and activity level. The study is a minimal risk study, with all subjects receiving the arch supports being investigated. There is no placebo offered. Initial evaluation of all subjects will include all imaging and measurements. Collection of subjective responses will occur after 4 weeks, 8 weeks, and 12 weeks of treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 13, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

July 14, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

1.6 years

First QC Date

July 14, 2025

Last Update Submit

August 4, 2025

Conditions

Keywords

arch supportsheel painmetatarsalgiaplantar fasciitis

Outcome Measures

Primary Outcomes (2)

  • Patient Reported Outcome Measurement Information System (PROMIS)-Pain Intensity Score

    Change in symptoms and relief of pain will be quantified based on subjective completion of validated questionnaires. Scoring is based on a 5-point scale, with higher scores indicating greater pain intensity. Raw scores are converted to T-scores, standardized to a mean of 50 (average for the general population) and a standard deviation of 10. Higher T-scores reflect more severe pain intensity.

    12 weeks

  • Patient Reported Outcome Measurement Information System (PROMIS)-Pain Interference Score

    PROMIS Pain Interference measures the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. Respondents rate how much pain has interfered with their daily life over the past 7 days. Scoring uses a 5-point scale, with higher scores indicating greater interference. Raw scores are converted to T-scores (mean = 50, SD = 10); higher T-scores represent more significant pain interference.

    12 weeks

Secondary Outcomes (3)

  • Change in foot morphology- Weightbearing X-ray

    Baseline

  • Change in foot morphology- Weightbearing CT scans

    Baseline

  • Patient Reported Outcome Measurement Information System (PROMIS)-Global Health

    12 weeks

Study Arms (1)

Inclusion 1. Men or women ≥ 18 and ≤ 65 years of age 2. The subject is able and willing to comply w

Subjects with foot pain who are able to wear arch supports.

Device: Arch supports

Interventions

Set of 3 arch supports supplied by Good Feet

Inclusion 1. Men or women ≥ 18 and ≤ 65 years of age 2. The subject is able and willing to comply w

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects will be recruited from the clinicians in the Division of Podiatry under the Department of Orthopaedics. Additionally, the sponsor, Good Feet Worldwide has a trade store the MGH service area, and will allow us to promote the study at their location with an advertisement poster. Potential subjects from the trade store will be referred to our clinics for screening and, when appropriate, recruited for the study.

You may qualify if:

  • Men or women ≥ 18 and ≤ 65 years of age
  • Able and willing to comply with study procedures, and a signed and dated
  • Diagnosed with symptomatic hallux valgus and/or plantar fasciitis and/or metatarsalgia
  • Has had foot pain for at least 30 days
  • Willing and able to utilize insole when walking for 90 days
  • BMI ≤ 35
  • Able to walk up to 0.5 miles without difficulty in a 24-hour period

You may not qualify if:

  • Inability or unwillingness to comply with study procedures
  • Gross asymmetry in feet, where shoe size differs by 2 or more full sizes between right and left foot
  • Subject has had a CT performed within the last 30 days, for any body part.
  • Prior partial or total amputation of a foot
  • BMI \> 35.
  • Unilateral or bilateral foot deformity that would hinder the fitting of an over-the-counter arch support, such as active Charcot foot or Charcot with boney prominence
  • Ulcers or open sores on either foot
  • Currently wearing custom shoes or insoles.
  • Currently ambulating with a cane, crutches, walker.
  • Currently using any type of foot or ankle brace, and/or having used a brace in the last 30 days.
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

MetatarsalgiaMorton NeuromaLow Back PainFasciitis, Plantar

Interventions

Foot Orthoses

Condition Hierarchy (Ancestors)

Foot DiseasesMusculoskeletal DiseasesJoint DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeuralgiaPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesBack PainFasciitis

Intervention Hierarchy (Ancestors)

Orthotic DevicesOrthopedic EquipmentSurgical EquipmentEquipment and Supplies

Study Officials

  • Adam S Landsman, DPM, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
12 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 14, 2025

First Posted

August 5, 2025

Study Start

June 13, 2022

Primary Completion

December 31, 2023

Study Completion

March 31, 2024

Last Updated

August 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

HIPPA compliance

Locations